vs
Douglas Emmett Inc（DEI）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Douglas Emmett Inc的季度营收约是Ultragenyx Pharmaceutical Inc.的1.2倍（$249.4M vs $207.3M），Douglas Emmett Inc净利率更高（-2.7% vs -62.0%，领先59.3%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 1.8%），Douglas Emmett Inc自由现金流更多（$194.5M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 0.9%）
道格拉斯·艾米特公司是一家领先的房地产投资信托企业，主要持有、运营及收购优质写字楼与多户住宅物业，核心市场覆盖加州洛杉矶、夏威夷州檀香山等准入门槛较高的区域，服务高端商业及住宅租户群体。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
DEI vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $249.4M | $207.3M |
| 净利润 | $-6.8M | $-128.6M |
| 毛利率 | 62.2% | — |
| 营业利润率 | — | -54.7% |
| 净利率 | -2.7% | -62.0% |
| 营收同比 | 1.8% | 25.9% |
| 净利润同比 | -670.7% | 3.5% |
| 每股收益（稀释后） | $-0.04 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $249.4M | $207.3M | ||
| Q3 25 | $250.6M | $159.9M | ||
| Q2 25 | $252.4M | $166.5M | ||
| Q1 25 | $251.5M | $139.3M | ||
| Q4 24 | $245.0M | $164.6M | ||
| Q3 24 | $250.8M | $139.5M | ||
| Q2 24 | $245.8M | $147.0M | ||
| Q1 24 | $245.0M | $108.8M |
| Q4 25 | $-6.8M | $-128.6M | ||
| Q3 25 | $-10.9M | $-180.4M | ||
| Q2 25 | $-5.8M | $-115.0M | ||
| Q1 25 | $39.8M | $-151.1M | ||
| Q4 24 | $-888.0K | $-133.2M | ||
| Q3 24 | $4.6M | $-133.5M | ||
| Q2 24 | $10.9M | $-131.6M | ||
| Q1 24 | $8.9M | $-170.7M |
| Q4 25 | 62.2% | — | ||
| Q3 25 | 63.6% | — | ||
| Q2 25 | 63.2% | — | ||
| Q1 25 | 64.4% | — | ||
| Q4 24 | 63.5% | — | ||
| Q3 24 | 62.2% | — | ||
| Q2 24 | 66.2% | — | ||
| Q1 24 | 66.1% | — |
| Q4 25 | — | -54.7% | ||
| Q3 25 | — | -106.9% | ||
| Q2 25 | — | -64.8% | ||
| Q1 25 | — | -102.6% | ||
| Q4 24 | — | -74.3% | ||
| Q3 24 | — | -94.6% | ||
| Q2 24 | — | -79.1% | ||
| Q1 24 | — | -151.9% |
| Q4 25 | -2.7% | -62.0% | ||
| Q3 25 | -4.3% | -112.8% | ||
| Q2 25 | -2.3% | -69.0% | ||
| Q1 25 | 15.8% | -108.5% | ||
| Q4 24 | -0.4% | -80.9% | ||
| Q3 24 | 1.8% | -95.7% | ||
| Q2 24 | 4.4% | -89.5% | ||
| Q1 24 | 3.6% | -156.8% |
| Q4 25 | $-0.04 | $-1.28 | ||
| Q3 25 | $-0.07 | $-1.81 | ||
| Q2 25 | $-0.04 | $-1.17 | ||
| Q1 25 | $0.24 | $-1.57 | ||
| Q4 24 | $-0.01 | $-1.34 | ||
| Q3 24 | $0.03 | $-1.40 | ||
| Q2 24 | $0.06 | $-1.52 | ||
| Q1 24 | $0.05 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $340.8M | $421.0M |
| 总债务越低越好 | $5.5B | — |
| 股东权益账面价值 | $1.9B | $-80.0M |
| 总资产 | $9.3B | $1.5B |
| 负债/权益比越低杠杆越低 | 2.91× | — |
8季度趋势，按日历期对齐
| Q4 25 | $340.8M | $421.0M | ||
| Q3 25 | $408.5M | $202.5M | ||
| Q2 25 | $426.9M | $176.3M | ||
| Q1 25 | $525.7M | $127.1M | ||
| Q4 24 | $444.6M | $174.0M | ||
| Q3 24 | $544.2M | $150.6M | ||
| Q2 24 | $561.1M | $480.7M | ||
| Q1 24 | $556.7M | $112.3M |
| Q4 25 | $5.5B | — | ||
| Q3 25 | $5.6B | — | ||
| Q2 25 | $5.6B | — | ||
| Q1 25 | $5.6B | — | ||
| Q4 24 | $5.5B | — | ||
| Q3 24 | $5.5B | — | ||
| Q2 24 | $5.5B | — | ||
| Q1 24 | $5.5B | — |
| Q4 25 | $1.9B | $-80.0M | ||
| Q3 25 | $1.9B | $9.2M | ||
| Q2 25 | $2.0B | $151.3M | ||
| Q1 25 | $2.0B | $144.2M | ||
| Q4 24 | $2.1B | $255.0M | ||
| Q3 24 | $2.1B | $346.8M | ||
| Q2 24 | $2.2B | $432.4M | ||
| Q1 24 | $2.2B | $140.3M |
| Q4 25 | $9.3B | $1.5B | ||
| Q3 25 | $9.4B | $1.2B | ||
| Q2 25 | $9.4B | $1.3B | ||
| Q1 25 | $9.6B | $1.3B | ||
| Q4 24 | $9.4B | $1.5B | ||
| Q3 24 | $9.5B | $1.5B | ||
| Q2 24 | $9.6B | $1.6B | ||
| Q1 24 | $9.6B | $1.3B |
| Q4 25 | 2.91× | — | ||
| Q3 25 | 2.85× | — | ||
| Q2 25 | 2.78× | — | ||
| Q1 25 | 2.75× | — | ||
| Q4 24 | 2.67× | — | ||
| Q3 24 | 2.64× | — | ||
| Q2 24 | 2.56× | — | ||
| Q1 24 | 2.52× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $386.9M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $194.5M | $-100.8M |
| 自由现金流率自由现金流/营收 | 78.0% | -48.6% |
| 资本支出强度资本支出/营收 | 77.1% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $376.9M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $386.9M | $-99.8M | ||
| Q3 25 | $109.8M | $-91.4M | ||
| Q2 25 | $81.3M | $-108.3M | ||
| Q1 25 | $132.6M | $-166.5M | ||
| Q4 24 | $408.7M | $-79.3M | ||
| Q3 24 | $103.7M | $-67.0M | ||
| Q2 24 | $91.9M | $-77.0M | ||
| Q1 24 | $139.0M | $-190.7M |
| Q4 25 | $194.5M | $-100.8M | ||
| Q3 25 | $61.9M | $-92.7M | ||
| Q2 25 | $30.2M | $-110.7M | ||
| Q1 25 | $90.3M | $-167.8M | ||
| Q4 24 | $241.4M | $-79.5M | ||
| Q3 24 | $63.2M | $-68.6M | ||
| Q2 24 | $52.2M | $-79.0M | ||
| Q1 24 | $90.9M | $-193.9M |
| Q4 25 | 78.0% | -48.6% | ||
| Q3 25 | 24.7% | -58.0% | ||
| Q2 25 | 11.9% | -66.5% | ||
| Q1 25 | 35.9% | -120.5% | ||
| Q4 24 | 98.5% | -48.3% | ||
| Q3 24 | 25.2% | -49.2% | ||
| Q2 24 | 21.2% | -53.7% | ||
| Q1 24 | 37.1% | -178.2% |
| Q4 25 | 77.1% | 0.5% | ||
| Q3 25 | 19.1% | 0.8% | ||
| Q2 25 | 20.3% | 1.5% | ||
| Q1 25 | 16.8% | 1.0% | ||
| Q4 24 | 68.3% | 0.1% | ||
| Q3 24 | 16.1% | 1.2% | ||
| Q2 24 | 16.1% | 1.4% | ||
| Q1 24 | 19.6% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.33× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 22.46× | — | ||
| Q2 24 | 8.44× | — | ||
| Q1 24 | 15.60× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DEI
| Rental Revenue And Tenant Recovery Revenue | $169.4M | 68% |
| Multifamily Segment | $49.9M | 20% |
| Parking Revenue And Other Income | $30.2M | 12% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
